Evidence map›Paper›PMID 37451272›Full record

ArticleCancer cell2023

Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling.

Hye-Min Jeon, Jeong-Yub Kim, Hee Jin Cho, Won Jun Lee, Dayna Nguyen, Sung Soo Kim, Young Taek Oh, Hee-Jin Kim, Chan-Woong Jung, Gonzalo Pinero and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
20.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.Journal of experimental & clinical cancer research : CR · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 2 countries.

Hye-Min JeonDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Jeong-Yub KimDivisions of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Hee Jin ChoDepartment of Biomedical Convergence Science and Technology, Kyungpook National University, Daegu, Korea.
Won Jun LeeDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Dayna NguyenDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Sung Soo KimDepartment of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Young Taek OhDepartment of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Hee-Jin KimDivisions of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Chan-Woong JungDivisions of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Gonzalo PineroIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Tanvi JoshiIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Dolores HambardzumyanIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Takuya SakaguchiDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Christopher G HubertDepartment of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Thomas M McIntyreDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Howard A FineDepartment of Neurology, Weill Cornell Medicine, New York, NY, USA.
Candece L GladsonDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Bingcheng WangDepartment of Medicine, MetroHealth Campus, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Benjamin W PurowDepartment of Neurology, UVA Cancer Center, University of Virginia Health System, Charlottesville, VA, USA.
Jong Bae ParkDepartment of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Myung Jin ParkDivisions of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center, Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Department of Neurosurgery Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jeongwu LeeDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: leej7@ccf.org.
Cleveland Clinic Lerner College of Medicine · USKorea Institute of Radiological and Medical Sciences · KRIcahn School of Medicine at Mount Sinai · USNational Cancer Center · KRCornell University · USKyungpook National University · KRMetroHealth Medical Center · USUniversity of Virginia Health System · US

Funding

(PQ1) HIV-infected T-cell exosomes in lung cancer progressionR01CA250067 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JIN, GE, WANG, BINGCHENG · 2020 to 2024
$3.7M
Targeting EphA2 in GlioblastomaR01NS096956 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI WANG, BINGCHENG · 2016 to 2021
$2.6M
Targeting oncogenic dopamine receptor signaling in glioblastomaR01CA223370 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI LEE, JEONGWU · 2019 to 2023
$2.4M
Hypertension augmented COVID-19 through renin-induced internalization of platelet-ACE2 / SARS-Cov-2 complexesR01HL158669 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MCINTYRE, THOMAS M · 2021 to 2024
$2.3M
Endocytic Trafficking of ADCs in GBM cancer stem-like cellsR01NS111981 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI CATHLEEN R CARLIN, Candece L Gladson · 2019 to 2026
$2.3M
Polycomb and Cellular Hierarchy in the BrainR01NS082312 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI LEE, JEONGWU · 2013 to 2017
$1.7M
NCI NIH HHS R01 CA223370NCI NIH HHS R01 CA250067NHLBI NIH HHS R01 HL158669NINDS NIH HHS R01 NS082312NINDS NIH HHS R01 NS096956NINDS NIH HHS R01 NS111981
6 · The paper itself

Abstract

Radiation therapy (RT) provides therapeutic benefits for patients with glioblastoma (GBM), but inevitably induces poorly understood global changes in GBM and its microenvironment (TME) that promote radio-resistance and recurrence. Through a cell surface marker screen, we identified that CD142 (tissue factor or F3) is robustly induced in the senescence-associated β-galactosidase (SA-βGal)-positive GBM cells after irradiation. F3 promotes clonal expansion of irradiated SA-βGal

Indexed as

Brain NeoplasmsGlioblastomaCell Line, TumorHumansNeoplasm Recurrence, LocalSignal TransductionThromboplastinTumor MicroenvironmentThromboplastinglioblastomasenescencetherapeutic resistancetissue factortumor microenvironment

Identifiers

PMID37451272
PMCPMC10530238
OpenAlexW4384207786

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.